Rumsfeld's growing stake in TamifluDefense Secretary, ex-chairman of flu treatment rights holder, sees portfolio value growing.October 31, 2005: 10:55 AM ESTBy Nelson D. Schwartz, Fortune senior writerNEW YORK (Fortune) - The prospect of a bird flu outbreak may be panicking people around the globe, but it's proving to be very good news for Defense Secretary Donald Rumsfeld and other politically connected investors in Gilead Sciences, the California biotech company that owns the rights to Tamiflu, the influenza remedy that's now the most-sought after drug in the world.
Want to see behind the curtain? Try
It's how we feed the squirrel
Sign up for the Fark NotNewsletter!
Links are submitted by members of the Fark community.
When community members submit a link, they also write a custom headline for the story.
Other Farkers comment on the links. This is the number of comments. Click here to read them.
You need to create an account to submit links or post comments.
Click here to submit a link.
Also on Fark
Submit a Link »
Copyright © 1999 - 2018 Fark, Inc | Last updated: Jan 18 2018 21:01:50
Runtime: 0.324 sec (324 ms)